Overview
Status
Active
Registry date
2017-01-30
Share capital
5,000.00 PLN
Registered address
ul. Prosta 67, 00-838 Warszawa, Poland
Electronic delivery address
AE:PL-32899-30680-IHIVD-18
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 80 days late).
- 202516/03/2026
- 202424/03/2025
- 202311/07/2024
- 202213/06/2023
- 202103/10/2022
- 202020/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 113.09kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD 11.07kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 102.02kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 38.76kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Ibrahim Naman Farr-Juriage 75 – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Pivotal S.l. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-07 | Address change (Grzybowska 5a, 00-132, Warszawa → Ul. Prosta 67, 00-838, Warszawa) | |
| 2019-01-11 | Address change (Ul. Koszykowa 54, 00-675, Warszawa → Grzybowska 5a, 00-132, Warszawa) | |
| 2017-11-07 | Address change (Ul. Rakowiecka 30a, 02-528, Warszawa → Ul. Koszykowa 54, 00-675, Warszawa) | |
| 2017-01-30 | Entered in the register |
FAQ
The main business activity of Pivotal Clinical focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 30, 2017.
The headquarters is located at: ul. Prosta 67, 00-838 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $113,087 in 2025.
Yes, the company recorded a net profit of $11,069 in 2025.
Last updated: 2026-10-07
